GALM抗体—艾普蒂

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Rat kidney tissue lysate, Primary antibody: P10385(GALM Antibody) at dilution 1/500, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 10 seconds    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human brain tissue using P10385(GALM Antibody) at dilution 1/35. (Original magnification: ×200)    

  
  

The GALM (galactose mutarotase) antibody is a research tool designed to detect and quantify the GALM enzyme, which plays a critical role in galactose metabolism. GALM catalyzes the conversion of β-D-galactose to α-D-galactose, a necessary step for galactose utilization via the Leloir pathway. Deficiencies or dysregulation of GALM are linked to metabolic disorders, including type 2 diabetes and rare forms of galactosemia, though its clinical significance is less well-characterized compared to other enzymes in the pathway (e.g., GALT).

GALM antibodies are typically produced in immunized hosts (e.g., rabbits, mice) using purified recombinant GALM protein or peptide fragments as antigens. These antibodies enable the study of GALM expression, localization, and function in tissues and cell lines through techniques like Western blotting, immunohistochemistry, and immunofluorescence. Recent studies have explored GALM's potential role in cancer progression and neurodegenerative diseases, driving demand for reliable antibodies to validate findings. Commercial GALM antibodies are often validated for specificity using knockout controls or siRNA-mediated silencing. However, researchers must verify cross-reactivity and batch consistency, as non-specific binding has been reported. Overall, GALM antibodies remain vital for elucidating the enzyme's biological and pathological mechanisms.